Report Highlights
The global DNA data storage market should reach $1.5 billion by 2027 from $105.5 million in 2022 at a compound annual growth rate (CAGR) of 69.8% for the forecast period of 2022 to 2027.
Report Includes
- 57 tables
- An up-to-date overview and analysis of the global markets for DNA data storage technologies
- Analyses of the global market trends, with historic revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the market potential for global DNA data storage technologies market, growth driving factors, and areas of focus to forecast this market into various segments and subsegments
- Estimation of the actual market size and revenue forecast for global DNA data storage market in USD million terms, and corresponding market share analysis by type, component, application, deployment, sequencing platform, end-user industry and region
- Understanding of the DNA data storage technologies; DNA sequencing (read) and synthesis (write) technologies; industry structure; large-scale DNA read, write and storage initiatives and population-scale sequencing projects
- Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors shaping the market demand for DNA data storage technologies over the coming years (2022-2027)
- Identification of the companies that are best positioned to meet this demand because of their proprietary technologies, strategic alliances, or other advantages
- Updated information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the global market
- Company profile descriptions of leading industry players, including 10x Genomics Inc., Agilent Technologies Inc., Illumina Inc., and Twist Bioscience Corp.
Report Scope
The scope of the report includes DNA data storage technologies, applications, industries, initiatives, patents, and companies. The market estimates for DNA data storage products and services are provided for 2020 as the base year, 2021, and forecast through year-end 2027.
This report reviews DNA data storage technologies, including DNA read and write technologies. It then discusses significant large-scale research initiatives that impact DNA storage, read, and write applications. The main market driving forces for DNA data storage products and services are discussed.
The report quantifies each of the main market segments for DNA data storage according to the following segments: by type (commercial, research, and prototyping); by deployment (cloud, on-premise); by application (archival, quality control, research, and prototyping); by end user (banking, financial services, and insurance; government and defense; healthcare and pharma; media and entertainment; and other); by sequencing platform (next generation sequencing, nanopore sequencing); by synthesis platform (chemical-column based; chemical-microchip based; enzymatic); and by geography (Asia-Pacific, Europe, North America, and Rest of the World).
The report also includes profiles of the key companies in the DNA data storage industry. In addition, BCC Research provides a summary of the main industry acquisitions and strategic alliances from January 2019 through December 2022, including key alliance trends.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Base year market size | $64.9 million | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market size forecast | $1.5 billion | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Growth rate | CAGR of 69.8% for the forecast period of 2022-2027 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segments covered | application, deployment, synthesis, sequencing technology, end-user, and region | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Countries covered | United States, Mexico, Canada, Austria, Belgium, Czech Republic, Denmark, Estonia, France, Finland, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, Switzerland, Turkey, United Kingdom, Australia, China, India, Japan, Malaysia, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Argentina, Brazil, Chile, Israel, Kuwait, Russia, Saudi Arabia, South Africa, United Arab Emirates | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for DNA data storage should grow from $36.4 million in 2020 to $525.3 million by 2025 with a compound annual growth rate (CAGR) of 70.6% for the period of 2020-2025.
Report Inludes
- 40 tables
- An overview of the global markets and technologies for DNA data storage
- Analyses of global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Description of DNA data storage technologies; DNA sequencing (read) and synthesis (write) technologies; industry structure; large-scale DNA read, write and storage initiatives and population-scale sequencing projects
- Details about components, deployment technologies and applications of DNA data storage
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size, and market forecast of the DNA data storage markets
- A look at the key industry acquisitions, strategic alliances and market share analysis of the leading suppliers of the industry
- Comprehensive profiles of major players in the industry, including Agilent Technologies Inc., Sigma Aldrich Corp., Generay Biotech Co. Ltd., Omega Bio-Tek Inc., Illumina Inc. and Thermo Fisher Scientific Inc.
Related Reports
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Synthetic Biology: Global Markets
The global market for synthetic biology products was valued at $15.4 billion in 2023. The market is projected to grow from $19.3 billion in 2024 to $61.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 26.1% from 2024 through 2029.
Gene Synthesis: Technologies and Global Markets
The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More